Boards

Board of Trustees

The Board of Trustees of Max Planck Florida Institute for Neuroscience is a group of dedicated professionals representing a variety of backgrounds and expertise. The Board actively participates in the guidance of the Institute towards fulfilling its mission while maintaining the highest standards of accountability.

As a public not-for-profit institution, the Institute takes seriously its responsibilities to maintain public trust and to integrate sound business practices into its daily operations. The Board reviews the Institute’s activities and progress towards its fundamental goal of conducting basic research to stimulate novel approaches in understanding the structure, function and development of neural circuits.

Dr. David C. Auth, Ph.D., P.E., NAE,
Chairman and CEO, Coaptus Medical Corporation

Mr. Mark W. Cook
President, Royal Palm Management

Mr. Alexander W. Dreyfoos
Chairman, The Dreyfoos Group

Mr. George Elmore
Founder and President, Hardrives, Inc.

Dr. David Fitzpatrick 
Scientific Director and Chief Executive Officer
Max Planck Florida Institute for Neuroscience

Judge Louis J. Freeh
Founder and Chairman, Freeh Group International Solutions,
LLC Founder and Partner, Freeh Sporkin & Sullivan, LLP

Mr. Frank J. Folz, III
Managing Director, AE Capital

Professor Dr. Bill S. Hansson
Chairman of the Board of Trustees
Director, Department of Evolutionary Neuroethology
Max Planck Institute for Chemical Ecology

Dr. Neen Hunt, Ed.D
President and Chief Executive Officer, The Mary Woodard Lasker Charitable Trust and the Albert and Mary Lasker Foundation, Inc.

Mr. Erik E. Joh, Esq.
Special Council, Hinman, Howard, & Kattel

Mr. Kenneth F. Kahn
President, LRP Publications

Mr. Nasser J. Kazeminy
Founder and Chairman, NJK Holding Corporation

Mrs. Becky Mayer
Co-leader of the Good Life Executive Seminars
for personal advancement

Hon. Bonnie McElveen-Hunter
CEO & Owner, Pace Communications

Mr. James R. Mellor
Chairman, USEC Inc.

Mr. Michael V. Mitrione
Co-Chair of Corporate Practice Group, Gunster, Yoakley & Stewart, P.A.

Mr. Gregory V. Novak
Vice-chair Intellectual Property Group, Co-Chair IP Litigation, Polsinelli, PC

Ms. Jane Panattoni
Philanthropist and Nonprofit Leader

Mr. Bernard J. Poussot
Retired Chairman, Wyeth

Mr. John Sculley
Chairman, RxAdvance

Mr. Markus Schleier
Max Planck Society for the Advancement of Science

Dr. James N. Weinstein
Immediate past CEO and President, Dartmouth-Hitchcock Health

Professor Dr. Peter Gruss – Chairman Emeritus
President, Max Planck Society for the Advancement
of Science (2002-2014)

 

Scientific Advisory Board

As a necessary compliment to the operational guidance provided by the institute’s Board of Trustees, MPFI is scientifically guided by a Scientific Advisory Board (SAB).

 

Every Max Planck Institute is regularly assessed by an SAB, and held meetings in 2014, 2016 and 2018. SAB members are experts chosen from leading research institutions and universities. The main responsibility of the SAB is to provide regular evaluations of the institute’s scientific performance.

Dr. Ann Graybiel
Massachusetts Institute of Technology

Dr. Michael Häusser
University College London

Dr. Anthony Movshon
New York University

Dr. Bernardo Sabatini
Harvard Medical School

Dr. Carla J. Shatz
Stanford University

Dr. Gary Westbrook
Vollum Institute